Literature DB >> 26032833

CGRP as a neuropeptide in migraine: lessons from mice.

Andrew F Russo1,2,3.   

Abstract

Migraine is a neurological disorder that is far more than just a bad headache. A hallmark of migraine is altered sensory perception. A likely contributor to this altered perception is the neuropeptide calcitonin gene-related peptide (CGRP). Over the past decade, CGRP has become firmly established as a key player in migraine. Although the mechanisms and sites of action by which CGRP might trigger migraine remain speculative, recent advances with mouse models provide some hints. This brief review focuses on how CGRP might act as both a central and peripheral neuromodulator to contribute to the migraine-like symptom of light aversive behaviour in mice.
© 2015 The British Pharmacological Society.

Entities:  

Keywords:  CGRP; calcitonin gene-related peptide; migraine; mouse model; neuropeptide; photophobia

Mesh:

Substances:

Year:  2015        PMID: 26032833      PMCID: PMC4574826          DOI: 10.1111/bcp.12686

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  140 in total

Review 1.  The role of mast cells in migraine pathophysiology.

Authors:  Theoharis C Theoharides; Jill Donelan; Kristiana Kandere-Grzybowska; Aphrodite Konstantinidou
Journal:  Brain Res Brain Res Rev       Date:  2005-07

Review 2.  Functional characteristics of the midbrain periaqueductal gray.

Authors:  M M Behbehani
Journal:  Prog Neurobiol       Date:  1995-08       Impact factor: 11.685

3.  Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.

Authors:  Y Huang; G Brodda-Jansen; T Lundeberg; L C Yu
Journal:  Brain Res       Date:  2000-08-04       Impact factor: 3.252

4.  The effects of central injections of calcitonin gene-related peptide on fear-related behavior.

Authors:  L H Poore; F J Helmstetter
Journal:  Neurobiol Learn Mem       Date:  1996-09       Impact factor: 2.877

Review 5.  Migraine pathophysiology: lessons from mouse models and human genetics.

Authors:  Michel D Ferrari; Roselin R Klever; Gisela M Terwindt; Cenk Ayata; Arn M J M van den Maagdenberg
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

6.  Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus.

Authors:  S Koulchitsky; M J M Fischer; K Messlinger
Journal:  Cephalalgia       Date:  2008-11-25       Impact factor: 6.292

7.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

8.  Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells.

Authors:  Jing Li; Carrie V Vause; Paul L Durham
Journal:  Brain Res       Date:  2008-01-25       Impact factor: 3.252

9.  Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension.

Authors:  Rasna Sabharwal; Zhongming Zhang; Yongjun Lu; Francois M Abboud; Andrew F Russo; Mark W Chapleau
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190

10.  Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.

Authors:  Carolyn Bernstein; Rami Burstein
Journal:  J Clin Neurol       Date:  2012-06-29       Impact factor: 3.077

View more
  17 in total

Review 1.  CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine.

Authors:  Heike Israel; Lars Neeb; Uwe Reuter
Journal:  Curr Pain Headache Rep       Date:  2018-04-06

Review 2.  Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation.

Authors:  Felipe A Pinho-Ribeiro; Waldiceu A Verri; Isaac M Chiu
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

Review 3.  CGRP in Animal Models of Migraine.

Authors:  Anne-Sophie Wattiez; Mengya Wang; Andrew F Russo
Journal:  Handb Exp Pharmacol       Date:  2019

Review 4.  Pain and immunity: implications for host defence.

Authors:  Pankaj Baral; Swalpa Udit; Isaac M Chiu
Journal:  Nat Rev Immunol       Date:  2019-07       Impact factor: 53.106

5.  Vascular Contributions to Migraine: Time to Revisit?

Authors:  Bianca N Mason; Andrew F Russo
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

6.  Essential role of endogenous calcitonin gene-related peptide in pain-associated plasticity in the central amygdala.

Authors:  Kei Shinohara; Ayako M Watabe; Masashi Nagase; Yuya Okutsu; Yukari Takahashi; Hiroki Kurihara; Fusao Kato
Journal:  Eur J Neurosci       Date:  2017-09-07       Impact factor: 3.386

7.  A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine.

Authors:  Bengt von Mentzer; Andrew F Russo; Zhongming Zhang; Adisa Kuburas; Patrick M Killoran; Vera D'Aloisio; Laura Nizic; Vicky Capel; David A Kendall; Christopher R Coxon; Gillian A Hutcheon
Journal:  J Pharm Pharmacol       Date:  2020-06-25       Impact factor: 3.765

Review 8.  Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.

Authors:  Rami Burstein; Andrew M Blumenfeld; Stephen D Silberstein; Aubrey Manack Adams; Mitchell F Brin
Journal:  Headache       Date:  2020-06-30       Impact factor: 5.887

9.  Peripherally administered calcitonin gene-related peptide induces spontaneous pain in mice: implications for migraine.

Authors:  Brandon J Rea; Anne-Sophie Wattiez; Jayme S Waite; William C Castonguay; Chantel M Schmidt; Aaron M Fairbanks; Bennett R Robertson; Cameron J Brown; Bianca N Mason; Maria-Cristina Moldovan-Loomis; Leon F Garcia-Martinez; Pieter Poolman; Johannes Ledolter; Randy H Kardon; Levi P Sowers; Andrew F Russo
Journal:  Pain       Date:  2018-11       Impact factor: 7.926

10.  Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment.

Authors:  Antoinette MaassenVanDenBrink; Gisela M Terwindt; Arn M J M van den Maagdenberg
Journal:  Genome Med       Date:  2018-02-22       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.